CN Patent

CN102947274A — 联苯基取代的1,3-二氢-苯并咪唑-2-亚基胺衍生物

Assigned to Novartis AG · Expires 2013-02-27 · 13y expired

What this patent protects

本发明涉及新的式(I)衍生物，其中取代基如说明书中所定义；制备此类衍生物的方法；包含此类衍生物的药物组合物；用作药物的此类衍生物；用于治疗一种或多种IGF-1R介导的病症或疾病的此类衍生物。

USPTO Abstract

本发明涉及新的式(I)衍生物，其中取代基如说明书中所定义；制备此类衍生物的方法；包含此类衍生物的药物组合物；用作药物的此类衍生物；用于治疗一种或多种IGF-1R介导的病症或疾病的此类衍生物。

Drugs covered by this patent

Patent Metadata

Patent number
CN102947274A
Jurisdiction
CN
Classification
—
Expires
2013-02-27
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.